The United States of America, as represented by The Secretary, Department of Health and Human Services;Marine Polymer Techologies, Inc.;The United States of America; as represented by The Secretary; Department of Health and Human Services
发明人:
Finkielsztein, Sergio,Vournakis, John N.,Pavlakis, George N.,Felber, Barbara K.
申请号：
AU2008269032
公开号：
AU2008269032B2
申请日:
2008.06.27
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention relates to agents that modulate interleυkin-15("IL-15") signal transduction or function ("TherapeuticAgents") and the use ol" those agents to modulate immune function.The Therapeutic Agents target the interaction between IL-15 and its receptorand modulate IL-15-induced signal transduction. The Therapeutic Agents maybe formulated with polymers, such as poly-β- 1- ♦4-N-acetylglucosamine.for administration to a human subject to modulate IL-15-mediated immune function.
